Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2023

Open Access 01-12-2023 | Human Immunodeficiency Virus | Research

Machine learning to predict virological failure among HIV patients on antiretroviral therapy in the University of Gondar Comprehensive and Specialized Hospital, in Amhara Region, Ethiopia, 2022

Authors: Daniel Niguse Mamo, Tesfahun Melese Yilma, Makida Fekadie, Yakub Sebastian, Tilahun Bizuayehu, Mequannent Sharew Melaku, Agmasie Damtew Walle

Published in: BMC Medical Informatics and Decision Making | Issue 1/2023

Login to get access

Abstract

Background

Treatment with effective antiretroviral therapy (ART) reduces viral load as well as HIV-related morbidity and mortality in HIV-positive patients. Despite the expanded availability of antiretroviral therapy around the world, virological failure remains a serious problem for HIV-positive patients. Thus, Machine learning predictive algorithms have the potential to improve the quality of care and predict the needs of HIV patients by analyzing huge amounts of data, and enhancing prediction capabilities. This study used different machine learning classification algorithms to predict the features that cause virological failure in HIV-positive patients.

Method

An institution-based secondary data was used to conduct patients who were on antiretroviral therapy at the University of Gondar Comprehensive and Specialized Hospital from January 2020 to May 2022. Patients’ data were extracted from the electronic database using a structured checklist and imported into Python version three software for data pre-processing and analysis. Then, seven supervised classification machine-learning algorithms for model development were trained. The performances of the predictive models were evaluated using accuracy, sensitivity, specificity, precision, f1-score, and AUC. Association rule mining was used to generate the best rule for the association between independent features and the target feature.

Result

Out of 5264 study participants, 1893 (35.06%) males and 3371 (64.04%) females were included. The random forest classifier (sensitivity = 1.00, precision = 0.987, f1-score = 0.993, AUC = 0.9989) outperformed in predicting virological failure among all selected classifiers. Random forest feature importance and association rules identified the top eight predictors (Male, younger age, longer duration on ART, not taking CPT, not taking TPT, secondary educational status, TDF-3TC-EFV, and low CD4 counts) of virological failure based on the importance ranking, and the CD-4 count was recognized as the most important predictor feature.

Conclusion

The random forest classifier outperformed in predicting and identifying the relevant predictors of virological failure. The results of this study could be very helpful to health professionals in determining the optimal virological outcome.
Literature
2.
go back to reference Lecher SL, Fonjungo P, Ellenberger D, Toure CA, Alemnji G, Bowen N, et al. HIV viral load monitoring among patients receiving antiretroviral therapy—eight Sub-Saharan Africa Countries, 2013–2018. Morb Mortal Wkly Rep. 2021;70(21):775.CrossRef Lecher SL, Fonjungo P, Ellenberger D, Toure CA, Alemnji G, Bowen N, et al. HIV viral load monitoring among patients receiving antiretroviral therapy—eight Sub-Saharan Africa Countries, 2013–2018. Morb Mortal Wkly Rep. 2021;70(21):775.CrossRef
9.
go back to reference Chhim K, Mburu G, Tuot S, Sopha R, Khol V, Chhoun P, et al. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study. AIDS Res therapy. 2018;15(1):1–10.CrossRef Chhim K, Mburu G, Tuot S, Sopha R, Khol V, Chhoun P, et al. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study. AIDS Res therapy. 2018;15(1):1–10.CrossRef
10.
go back to reference World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016.
12.
go back to reference Vidal JE, Song ATW, Matos ML, et al. High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil. Braz J Infect Dis. 2013;17(1):41–7.PubMedPubMedCentralCrossRef Vidal JE, Song ATW, Matos ML, et al. High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil. Braz J Infect Dis. 2013;17(1):41–7.PubMedPubMedCentralCrossRef
13.
go back to reference Liégeois F, Vella C, Eymard-Duvernay S, et al. Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc. 2012;15(2):17985.PubMedPubMedCentralCrossRef Liégeois F, Vella C, Eymard-Duvernay S, et al. Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc. 2012;15(2):17985.PubMedPubMedCentralCrossRef
14.
go back to reference Meriki HD, Tufon KA, Afegenwi MH, et al. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty. 2014;3:5.PubMedPubMedCentralCrossRef Meriki HD, Tufon KA, Afegenwi MH, et al. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty. 2014;3:5.PubMedPubMedCentralCrossRef
15.
go back to reference Kitchen CM, Kitchen SG, Dubin JA, Gottlieb MS. Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome. Clin Infect Dis. 2001;33(4):466–72.PubMedCrossRef Kitchen CM, Kitchen SG, Dubin JA, Gottlieb MS. Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome. Clin Infect Dis. 2001;33(4):466–72.PubMedCrossRef
16.
go back to reference McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review. Bull World Health Organ. 2013;91(5):377–85.PubMedPubMedCentralCrossRef McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review. Bull World Health Organ. 2013;91(5):377–85.PubMedPubMedCentralCrossRef
17.
go back to reference Barth RE, van der Loeff MFS, Schuurman R, Hoepelman AI, Wensing AM. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-saharan Africa: a systematic review. Lancet Infect Dis. 2010;10(3):155–66.PubMedCrossRef Barth RE, van der Loeff MFS, Schuurman R, Hoepelman AI, Wensing AM. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-saharan Africa: a systematic review. Lancet Infect Dis. 2010;10(3):155–66.PubMedCrossRef
18.
go back to reference Abdissa A, Yilma D, Fonager J, Audelin AM, Christensen LH, Olsen MF, et al. Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. BMC Infect Dis. 2014;14(1):181.PubMedPubMedCentralCrossRef Abdissa A, Yilma D, Fonager J, Audelin AM, Christensen LH, Olsen MF, et al. Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia. BMC Infect Dis. 2014;14(1):181.PubMedPubMedCentralCrossRef
19.
go back to reference Bernabé KJ, Siedner M, Tsai AC, Marconi VC, Murphy RA. Detection of HIV Virologic failure and switch to second-line therapy: a systematic review and Meta-analysis of Data from Sub-Saharan Africa. Open Forum Infect Dis. 2022;9(5):ofac121.PubMedPubMedCentralCrossRef Bernabé KJ, Siedner M, Tsai AC, Marconi VC, Murphy RA. Detection of HIV Virologic failure and switch to second-line therapy: a systematic review and Meta-analysis of Data from Sub-Saharan Africa. Open Forum Infect Dis. 2022;9(5):ofac121.PubMedPubMedCentralCrossRef
20.
go back to reference Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, et al. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS. 2014;28(14):2097.PubMedCrossRef Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, et al. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS. 2014;28(14):2097.PubMedCrossRef
21.
go back to reference World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021. Accessed on 28 July 2022. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021. Accessed on 28 July 2022.
22.
go back to reference Zenu S, Tesema T, Reshad M, Abebe E. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study. PLoS ONE. 2021;16(10):e0258930.PubMedPubMedCentralCrossRef Zenu S, Tesema T, Reshad M, Abebe E. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study. PLoS ONE. 2021;16(10):e0258930.PubMedPubMedCentralCrossRef
23.
go back to reference Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):460.PubMedPubMedCentralCrossRef Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):460.PubMedPubMedCentralCrossRef
24.
go back to reference Murphy RA, Court R, Maartens G, Sunpath H. Second-line antiretroviral therapy in sub-saharan Africa: it is time to mind the gaps. AIDS Res Hum Retroviruses. 2017;33(12):1181–4.PubMedPubMedCentralCrossRef Murphy RA, Court R, Maartens G, Sunpath H. Second-line antiretroviral therapy in sub-saharan Africa: it is time to mind the gaps. AIDS Res Hum Retroviruses. 2017;33(12):1181–4.PubMedPubMedCentralCrossRef
25.
go back to reference Seyler L, Lacor P, Allard SD. Current challenges in the treatment of HIV. Pol Arch Intern Med. 2018;128(10):609–16.PubMedCrossRef Seyler L, Lacor P, Allard SD. Current challenges in the treatment of HIV. Pol Arch Intern Med. 2018;128(10):609–16.PubMedCrossRef
26.
go back to reference Ansah D, Kumah E, Bawontuo V, Agyei-Baffour P, Afriyie EK. Determinants of viral load non-suppression among people living with HIV on antiretroviral therapy in Kumasi, Ghana. Ghana Med J. 2021;55(2):111–7.CrossRef Ansah D, Kumah E, Bawontuo V, Agyei-Baffour P, Afriyie EK. Determinants of viral load non-suppression among people living with HIV on antiretroviral therapy in Kumasi, Ghana. Ghana Med J. 2021;55(2):111–7.CrossRef
27.
go back to reference Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. BMC Infect Dis. 2017;17(1):1–11.CrossRef Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. BMC Infect Dis. 2017;17(1):1–11.CrossRef
28.
go back to reference Gupta-Wright A, Fielding K, van Oosterhout JJ, Alufandika M, Grint DJ, Chimbayo E, et al. Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. The Lancet HIV. 2020;7(9):e620–8.PubMedPubMedCentralCrossRef Gupta-Wright A, Fielding K, van Oosterhout JJ, Alufandika M, Grint DJ, Chimbayo E, et al. Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. The Lancet HIV. 2020;7(9):e620–8.PubMedPubMedCentralCrossRef
29.
go back to reference Gumede SB, Venter WDF, Lalla-Edward ST. Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment. South Afr J HIV Med. 2020;21(1):1–0.CrossRef Gumede SB, Venter WDF, Lalla-Edward ST. Understanding adherence in virally suppressed and unsuppressed human immunodeficiency virus-positive urban patients on second-line antiretroviral treatment. South Afr J HIV Med. 2020;21(1):1–0.CrossRef
30.
go back to reference Fentie Wendie T, Workneh BD. Prevalence and predictors of virological failure among adults living with HIV in South Wollo Zone, Northeast Ethiopia: a retrospective cohort study. HIV AIDS (Auckl). 2020;12:393–402.PubMed Fentie Wendie T, Workneh BD. Prevalence and predictors of virological failure among adults living with HIV in South Wollo Zone, Northeast Ethiopia: a retrospective cohort study. HIV AIDS (Auckl). 2020;12:393–402.PubMed
31.
go back to reference Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS ONE. 2018;13(5):e0196259.PubMedPubMedCentralCrossRef Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS ONE. 2018;13(5):e0196259.PubMedPubMedCentralCrossRef
32.
go back to reference Negash H, Welay M, Legese H, Adhanom G, Mardu F, Tesfay K, et al. Increased virological failure and determinants among HIV patients on highly active retroviral therapy in Adigrat General Hospital, Northern Ethiopia, 2019: hospital-based cross-sectional study. Infect drug Resist. 2020;13:1863–72.PubMedPubMedCentralCrossRef Negash H, Welay M, Legese H, Adhanom G, Mardu F, Tesfay K, et al. Increased virological failure and determinants among HIV patients on highly active retroviral therapy in Adigrat General Hospital, Northern Ethiopia, 2019: hospital-based cross-sectional study. Infect drug Resist. 2020;13:1863–72.PubMedPubMedCentralCrossRef
33.
go back to reference Meshesha HM, Nigussie ZM, Asrat A, Mulatu K. Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case–control study. BMJ Open. 2020;10(7):e036223.PubMedPubMedCentralCrossRef Meshesha HM, Nigussie ZM, Asrat A, Mulatu K. Determinants of virological failure among adults on first-line highly active antiretroviral therapy at public health facilities in Kombolcha town, Northeast, Ethiopia: a case–control study. BMJ Open. 2020;10(7):e036223.PubMedPubMedCentralCrossRef
34.
go back to reference Fentaw Z, Molla A, Wedajo S, Mebratu W. Determinants of virological failure among adult clients on first-line antiretroviral therapy in Amhara Regional State, Northeast Ethiopia. A case -control study. HIV AIDS (Auckl). 2020;12:749–56.PubMed Fentaw Z, Molla A, Wedajo S, Mebratu W. Determinants of virological failure among adult clients on first-line antiretroviral therapy in Amhara Regional State, Northeast Ethiopia. A case -control study. HIV AIDS (Auckl). 2020;12:749–56.PubMed
35.
go back to reference Mziray SR, Kumburu HH, Assey HB, Sonda TB, Mahande MJ, Msuya SE, et al. Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania. PLoS ONE. 2020;15(9):e0232649.PubMedPubMedCentralCrossRef Mziray SR, Kumburu HH, Assey HB, Sonda TB, Mahande MJ, Msuya SE, et al. Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania. PLoS ONE. 2020;15(9):e0232649.PubMedPubMedCentralCrossRef
36.
go back to reference Samizi FG, Panga OD, Mulugu SS, Gitige CG, Mmbaga EJ. Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania. J Infect Developing Ctries. 2021;15(06):853–60.CrossRef Samizi FG, Panga OD, Mulugu SS, Gitige CG, Mmbaga EJ. Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania. J Infect Developing Ctries. 2021;15(06):853–60.CrossRef
37.
go back to reference Brnabic A, Hess LM. Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making. BMC Med Inform Decision Making. 2021;21(1):1–19.CrossRef Brnabic A, Hess LM. Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making. BMC Med Inform Decision Making. 2021;21(1):1–19.CrossRef
39.
go back to reference Supriya M, Deepa AJ. Machine learning approach on healthcare big data: A review. Big Data Inform Anal. 2020;5(1):58–75.CrossRef Supriya M, Deepa AJ. Machine learning approach on healthcare big data: A review. Big Data Inform Anal. 2020;5(1):58–75.CrossRef
40.
go back to reference Ekpenyong ME, Etebong PI, Jackson TC. Fuzzy-multidimensional deep learning for efficient prediction of patient response to antiretroviral therapy. Heliyon. 2019;5(7):e02080.PubMedPubMedCentralCrossRef Ekpenyong ME, Etebong PI, Jackson TC. Fuzzy-multidimensional deep learning for efficient prediction of patient response to antiretroviral therapy. Heliyon. 2019;5(7):e02080.PubMedPubMedCentralCrossRef
41.
go back to reference Bisaso KR, Anguzu GT, Karungi SA, Kiragga A, Castelnuovo B. A survey of machine learning applications in HIV clinical research and care. Comput Biol Med. 2017;91:366–71.PubMedCrossRef Bisaso KR, Anguzu GT, Karungi SA, Kiragga A, Castelnuovo B. A survey of machine learning applications in HIV clinical research and care. Comput Biol Med. 2017;91:366–71.PubMedCrossRef
42.
go back to reference Orel E, Esra R, Estill J, Thiabaud A, Marchand-Maillet S, Merzouki A, et al. Prediction of HIV status based on socio-behavioural characteristics in East and Southern Africa. PLoS ONE. 2022;17(3):e0264429.PubMedPubMedCentralCrossRef Orel E, Esra R, Estill J, Thiabaud A, Marchand-Maillet S, Merzouki A, et al. Prediction of HIV status based on socio-behavioural characteristics in East and Southern Africa. PLoS ONE. 2022;17(3):e0264429.PubMedPubMedCentralCrossRef
43.
go back to reference Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inf Decis Mak. 2019;19(1):1–16. Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inf Decis Mak. 2019;19(1):1–16.
44.
go back to reference Maskew M, Sharpey-Schafer K, De Voux L, Crompton T, Bor J, Rennick M, et al. Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts. Sci Rep. 2022;12(1):12715.PubMedPubMedCentralCrossRef Maskew M, Sharpey-Schafer K, De Voux L, Crompton T, Bor J, Rennick M, et al. Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts. Sci Rep. 2022;12(1):12715.PubMedPubMedCentralCrossRef
45.
go back to reference Young SD, Yu W, Wang W. Toward automating HIV identification: machine learning for rapid identification of HIV-related social media data. J Acquir Immune Defic Syndr. 2017;74(Suppl 2):128.CrossRef Young SD, Yu W, Wang W. Toward automating HIV identification: machine learning for rapid identification of HIV-related social media data. J Acquir Immune Defic Syndr. 2017;74(Suppl 2):128.CrossRef
46.
go back to reference Nega J, Taye S, Million Y, Rodrigo C, Eshetie S. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia. AIDS Res Ther. 2020;17(1):1–9.CrossRef Nega J, Taye S, Million Y, Rodrigo C, Eshetie S. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia. AIDS Res Ther. 2020;17(1):1–9.CrossRef
47.
go back to reference Mulisa D, Tesfa M, Mullu Kassa G, Tolossa T. Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study. BMC Infect Dis. 2019;19(1):1–13.CrossRef Mulisa D, Tesfa M, Mullu Kassa G, Tolossa T. Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study. BMC Infect Dis. 2019;19(1):1–13.CrossRef
48.
go back to reference Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: A systematic review and meta-analysis. Glob Health Res Policy. 2019;4(1):1–10.CrossRef Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: A systematic review and meta-analysis. Glob Health Res Policy. 2019;4(1):1–10.CrossRef
50.
go back to reference Pedregosa FaV G, Gramfort A, Michel V, Thirion BaG O, Blondel M, Prettenhofer P, Weiss RaD V, Vanderplas J, Passos A, Cournapeau DaB M, Perrot M, Duchesnay E. Scikit-learn Machine Learning in Python. 2011;12:2825–30. Pedregosa FaV G, Gramfort A, Michel V, Thirion BaG O, Blondel M, Prettenhofer P, Weiss RaD V, Vanderplas J, Passos A, Cournapeau DaB M, Perrot M, Duchesnay E. Scikit-learn Machine Learning in Python. 2011;12:2825–30.
51.
go back to reference Al-Shehari T, Alsowail RA. An insider data leakage detection using one-hot encoding, synthetic minority oversampling and machine learning techniques. Entropy. 2021;23(10):1258.PubMedPubMedCentralCrossRef Al-Shehari T, Alsowail RA. An insider data leakage detection using one-hot encoding, synthetic minority oversampling and machine learning techniques. Entropy. 2021;23(10):1258.PubMedPubMedCentralCrossRef
52.
go back to reference Muller AC, Guido S. Introduction to machine learning with Python: a guide for data scientists. USA: O’Reilly Media, Inc.; 2016. Muller AC, Guido S. Introduction to machine learning with Python: a guide for data scientists. USA: O’Reilly Media, Inc.; 2016.
53.
go back to reference McKinney W. Python for data analysis: Data wrangling with Pandas, NumPy, and IPython. USA: O’Reilly Media, Inc.; 2012. McKinney W. Python for data analysis: Data wrangling with Pandas, NumPy, and IPython. USA: O’Reilly Media, Inc.; 2012.
54.
go back to reference Gnana DAA, Balamurugan SAA, Leavline EJ. Literature review on feature selection methods for high-dimensional data. Int J Comput Appl. 2016;136(1):9–17. Gnana DAA, Balamurugan SAA, Leavline EJ. Literature review on feature selection methods for high-dimensional data. Int J Comput Appl. 2016;136(1):9–17.
55.
go back to reference Cai J, Luo J, Wang S, Yang S. Feature selection in machine learning: a new perspective. Neurocomputing. 2018;300:70–9.CrossRef Cai J, Luo J, Wang S, Yang S. Feature selection in machine learning: a new perspective. Neurocomputing. 2018;300:70–9.CrossRef
56.
go back to reference Saxena A, Ganguly A, Shrivastava AK. Predicting Chronic Kidney Disease Risk Using Recursive Feature Elimination and Machine Learning. 2020;4(5):1–7. Saxena A, Ganguly A, Shrivastava AK. Predicting Chronic Kidney Disease Risk Using Recursive Feature Elimination and Machine Learning. 2020;4(5):1–7.
57.
go back to reference Kamal S, Urata J, Cavassini M, Liu H, Kouyos R, Bugnon O, et al. Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence. AIDS care. 2021;33(4):530-6. PubMedCrossRef Kamal S, Urata J, Cavassini M, Liu H, Kouyos R, Bugnon O, et al. Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence. AIDS care. 2021;33(4):530-6. PubMedCrossRef
58.
go back to reference Olayemi Olufunke C, Olasehinde Olayemi O, Agbelusi O. Predictive model of pediatric hiv/aids survival in nigeria using support vector machine. Communications. 2016;5:29–36. Olayemi Olufunke C, Olasehinde Olayemi O, Agbelusi O. Predictive model of pediatric hiv/aids survival in nigeria using support vector machine. Communications. 2016;5:29–36.
60.
go back to reference Alghamdi M, Al-Mallah M, Keteyian S, Brawner C, Ehrman J, Sakr S. Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: the Henry Ford ExercIse Testing (FIT) project. PLoS ONE. 2017;12(7):e0179805.PubMedPubMedCentralCrossRef Alghamdi M, Al-Mallah M, Keteyian S, Brawner C, Ehrman J, Sakr S. Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: the Henry Ford ExercIse Testing (FIT) project. PLoS ONE. 2017;12(7):e0179805.PubMedPubMedCentralCrossRef
61.
go back to reference Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321–57.CrossRef Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321–57.CrossRef
62.
go back to reference Desalegn M, Seyoum D, Tola EK, Tsegaye Gayesa R. Determinants of first-line antiretroviral treatment failure among adult HIV patients at Nekemte Specialized Hospital, Western Ethiopia: Unmatched case-control study. SAGE Open Med. 2021;9:20503121211030184.PubMedPubMedCentralCrossRef Desalegn M, Seyoum D, Tola EK, Tsegaye Gayesa R. Determinants of first-line antiretroviral treatment failure among adult HIV patients at Nekemte Specialized Hospital, Western Ethiopia: Unmatched case-control study. SAGE Open Med. 2021;9:20503121211030184.PubMedPubMedCentralCrossRef
63.
go back to reference Wang S, Dai Y, Shen J, Xuan J. Research on expansion and classification of imbalanced data based on SMOTE algorithm. Sci Rep. 2021;11(1):1–11.CrossRef Wang S, Dai Y, Shen J, Xuan J. Research on expansion and classification of imbalanced data based on SMOTE algorithm. Sci Rep. 2021;11(1):1–11.CrossRef
64.
go back to reference Haibo He, Yang Bai, Garcia EA, Shutao Li. "ADASYN: Adaptive synthetic sampling approach for imbalanced learning" 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence). Hong Kong. 2008;1322-1328. https://doi.org/10.1109/IJCNN.2008.4633969. Haibo He, Yang Bai, Garcia EA, Shutao Li. "ADASYN: Adaptive synthetic sampling approach for imbalanced learning" 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence). Hong Kong. 2008;1322-1328. https://​doi.​org/​10.​1109/​IJCNN.​2008.​4633969.
65.
go back to reference Kaur H, Pannu HS, Malhi AK. A systematic review on imbalanced data challenges in machine learning: applications and solutions. ACM Comput Surv (CSUR). 2019;52(4):1–36. Kaur H, Pannu HS, Malhi AK. A systematic review on imbalanced data challenges in machine learning: applications and solutions. ACM Comput Surv (CSUR). 2019;52(4):1–36.
66.
67.
go back to reference Bisaso KR, Anguzu GT, Karungi SA, Kiragga A, Castelnuovo B. A survey of machine learning applications in HIV clinical research and care. Comput Biol Med. 2017;91:366–71.PubMedCrossRef Bisaso KR, Anguzu GT, Karungi SA, Kiragga A, Castelnuovo B. A survey of machine learning applications in HIV clinical research and care. Comput Biol Med. 2017;91:366–71.PubMedCrossRef
68.
go back to reference Cai Q, Yuan R, He J, Li M, Guo Y. Predicting HIV drug resistance using weighted machine learning method at target protein sequence-level. Mol Diversity. 2021;25(3):1541–51.CrossRef Cai Q, Yuan R, He J, Li M, Guo Y. Predicting HIV drug resistance using weighted machine learning method at target protein sequence-level. Mol Diversity. 2021;25(3):1541–51.CrossRef
69.
go back to reference Olatosi B, Sun X, Chen S, Zhang J, Liang C, Weissman S, et al. Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina. Aids. 2021;35(Suppl 1):S19-S28.PubMedCrossRef Olatosi B, Sun X, Chen S, Zhang J, Liang C, Weissman S, et al. Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina. Aids. 2021;35(Suppl 1):S19-S28.PubMedCrossRef
70.
go back to reference Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE. 2015;10(3):e0118432.PubMedPubMedCentralCrossRef Saito T, Rehmsmeier M. The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets. PLoS ONE. 2015;10(3):e0118432.PubMedPubMedCentralCrossRef
71.
go back to reference Chicco D, Jurman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21(1):1–13.CrossRef Chicco D, Jurman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21(1):1–13.CrossRef
72.
go back to reference Agrawal R, Imieliński T, Swami A. Mining association rules between sets of items in large databases. ACM SIGMOD Record. 1993;22(2):207–16.CrossRef Agrawal R, Imieliński T, Swami A. Mining association rules between sets of items in large databases. ACM SIGMOD Record. 1993;22(2):207–16.CrossRef
73.
go back to reference Harahap M, Husein AM, Aisyah S, Lubis FR, Wijaya BA, editors. Mining association rule based on the diseases population for recommendation of medicine need. J Physics Conf Ser; 2018. p. 012017. Harahap M, Husein AM, Aisyah S, Lubis FR, Wijaya BA, editors. Mining association rule based on the diseases population for recommendation of medicine need. J Physics Conf Ser; 2018. p. 012017.
74.
go back to reference Altaf W, Shahbaz M, Guergachi A. Applications of association rule mining in health informatics: a survey. Artif Intell Rev. 2017;47(3):313–40.CrossRef Altaf W, Shahbaz M, Guergachi A. Applications of association rule mining in health informatics: a survey. Artif Intell Rev. 2017;47(3):313–40.CrossRef
76.
go back to reference Lateh Masitah Abdul, Muda Azah Kamilah, Yusof Zeratul Izzah M, Muda Noor Azilah, Azmi Mohd Sanusi, editors. Handling a Small Dataset Problem in Prediction Model by employ Artificial Data Generation Approach. Rev J Phys Conf Ser. IOP Publishing; 2017. Lateh Masitah Abdul, Muda Azah Kamilah, Yusof Zeratul Izzah M, Muda Noor Azilah, Azmi Mohd Sanusi, editors. Handling a Small Dataset Problem in Prediction Model by employ Artificial Data Generation Approach. Rev J Phys Conf Ser. IOP Publishing; 2017.
77.
go back to reference Chen S, Owolabi Y, Dulin M, Robinson P, Witt B, Samoff E. Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA. AIDS. 2021;35(Suppl 1):29–S38.CrossRef Chen S, Owolabi Y, Dulin M, Robinson P, Witt B, Samoff E. Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA. AIDS. 2021;35(Suppl 1):29–S38.CrossRef
78.
go back to reference Kebede M, Zegeye DT, Zeleke BM. Predicting CD4 count changes among patients on antiretroviral treatment: application of data mining techniques. Comput Methods Programs Biomed. 2017;152:149–57.PubMedCrossRef Kebede M, Zegeye DT, Zeleke BM. Predicting CD4 count changes among patients on antiretroviral treatment: application of data mining techniques. Comput Methods Programs Biomed. 2017;152:149–57.PubMedCrossRef
79.
go back to reference Hicham T, Ilyas E, Tarik H, Noureddine B, Omar B, Rachid F, et al. Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco. Int J Mycobacteriology. 2019;8(2):113–7. Hicham T, Ilyas E, Tarik H, Noureddine B, Omar B, Rachid F, et al. Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco. Int J Mycobacteriology. 2019;8(2):113–7.
80.
go back to reference Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):1–10.CrossRef Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):1–10.CrossRef
81.
go back to reference Rupérez M, Pou C, Maculuve S, Cedeno S, Luis L, Rodríguez J, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother. 2015;70(9):2639–47.PubMedCrossRef Rupérez M, Pou C, Maculuve S, Cedeno S, Luis L, Rodríguez J, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother. 2015;70(9):2639–47.PubMedCrossRef
82.
go back to reference Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study. Hiv/aids (Auckland NZ). 2017;9:153–9. Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study. Hiv/aids (Auckland NZ). 2017;9:153–9.
83.
go back to reference Babo YD, Alemie GA, Fentaye FW. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. PLoS ONE. 2017;12(11):e0187694.PubMedPubMedCentralCrossRef Babo YD, Alemie GA, Fentaye FW. Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. PLoS ONE. 2017;12(11):e0187694.PubMedPubMedCentralCrossRef
84.
go back to reference Agezew T, Tadesse A, Derseh L, Yimer M. Incidence and predictors of first line anti-retroviral therapy failure among adults receiving HIV care in North West Ethiopia: a hospital-based follow-up study. J Infect Dis Epidemiol. 2019;5(2):345. Agezew T, Tadesse A, Derseh L, Yimer M. Incidence and predictors of first line anti-retroviral therapy failure among adults receiving HIV care in North West Ethiopia: a hospital-based follow-up study. J Infect Dis Epidemiol. 2019;5(2):345.
85.
go back to reference Eshleman SH, Wilson EA, Zhang XC, Ou S-S, Piwowar-Manning E, Eron JJ, et al. Virologic outcomes in early antiretroviral treatment: HPTN 052. HIV Clin Trial. 2017;18(3):100–9.CrossRef Eshleman SH, Wilson EA, Zhang XC, Ou S-S, Piwowar-Manning E, Eron JJ, et al. Virologic outcomes in early antiretroviral treatment: HPTN 052. HIV Clin Trial. 2017;18(3):100–9.CrossRef
86.
go back to reference Emagnu A, Abay Z, Bulti AB, Animut Y. Determinants of virologic failure among adult HIV patients on first-line antiretroviral therapy at waghimra zone, northern Ethiopia: a case-control study. Advances in Public Health. 2020;2020:1–8.CrossRef Emagnu A, Abay Z, Bulti AB, Animut Y. Determinants of virologic failure among adult HIV patients on first-line antiretroviral therapy at waghimra zone, northern Ethiopia: a case-control study. Advances in Public Health. 2020;2020:1–8.CrossRef
87.
go back to reference Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):1–7.CrossRef Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):1–7.CrossRef
88.
go back to reference Abdullahi IJ, Deybasso HA, Adlo AM. Determinants of virological failure among patients on first-line antiretroviral therapy in central Oromia, Ethiopia: a case–control study. Hiv/aids (Auckland NZ). 2020;12:931–9. Abdullahi IJ, Deybasso HA, Adlo AM. Determinants of virological failure among patients on first-line antiretroviral therapy in central Oromia, Ethiopia: a case–control study. Hiv/aids (Auckland NZ). 2020;12:931–9.
89.
go back to reference Polyak CS, Yuhas K, Singa B, Khaemba M, Walson J, Richardson BA, et al. Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1-infected adults in Kenya: a randomized non-inferiority trial. PLoS Med. 2016;13(1):e1001934.PubMedPubMedCentralCrossRef Polyak CS, Yuhas K, Singa B, Khaemba M, Walson J, Richardson BA, et al. Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1-infected adults in Kenya: a randomized non-inferiority trial. PLoS Med. 2016;13(1):e1001934.PubMedPubMedCentralCrossRef
90.
go back to reference Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):1–14.CrossRef Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):1–14.CrossRef
91.
go back to reference Qin S, Lai J, Zhang H, Wei D, Lv Q, Pan X, et al. Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy. BMC Infect Dis. 2021;21(1):1–11.CrossRef Qin S, Lai J, Zhang H, Wei D, Lv Q, Pan X, et al. Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy. BMC Infect Dis. 2021;21(1):1–11.CrossRef
92.
go back to reference Ayele HT, Mourik MSv, Debray TP, Bonten MJ. Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials. PLoS ONE. 2015;10(11):e0142290.PubMedPubMedCentralCrossRef Ayele HT, Mourik MSv, Debray TP, Bonten MJ. Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials. PLoS ONE. 2015;10(11):e0142290.PubMedPubMedCentralCrossRef
93.
go back to reference Getaneh T, Negesse A, Dessie G, Desta M. The impact of tuberculosis co-infection on virological failure among adults living with HIV in Ethiopia: A systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis. 2022;27:100310.PubMedPubMedCentralCrossRef Getaneh T, Negesse A, Dessie G, Desta M. The impact of tuberculosis co-infection on virological failure among adults living with HIV in Ethiopia: A systematic review and meta-analysis. J Clin Tuberc Other Mycobact Dis. 2022;27:100310.PubMedPubMedCentralCrossRef
94.
go back to reference Ojha CR, Shakya G, Dumre SP. Virological and immunological status of the people living with HIV/AIDS undergoing ART treatment in Nepal. Biomed Res Int. 2016;2016:6817325.PubMedPubMedCentralCrossRef Ojha CR, Shakya G, Dumre SP. Virological and immunological status of the people living with HIV/AIDS undergoing ART treatment in Nepal. Biomed Res Int. 2016;2016:6817325.PubMedPubMedCentralCrossRef
95.
go back to reference Mouton DC, Gonzo M, Mukesi M. Viral load suppression as a surrogate marker of treatment success in patients on antiretroviral therapy in Namibia. Edorium J Biomed Sci. 2017;2:1–8. Mouton DC, Gonzo M, Mukesi M. Viral load suppression as a surrogate marker of treatment success in patients on antiretroviral therapy in Namibia. Edorium J Biomed Sci. 2017;2:1–8.
Metadata
Title
Machine learning to predict virological failure among HIV patients on antiretroviral therapy in the University of Gondar Comprehensive and Specialized Hospital, in Amhara Region, Ethiopia, 2022
Authors
Daniel Niguse Mamo
Tesfahun Melese Yilma
Makida Fekadie
Yakub Sebastian
Tilahun Bizuayehu
Mequannent Sharew Melaku
Agmasie Damtew Walle
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2023
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-023-02167-7

Other articles of this Issue 1/2023

BMC Medical Informatics and Decision Making 1/2023 Go to the issue